Aiberry, founded with a mission to revolutionize mental health care, leverages artificial intelligence to provide efficient and accurate mental health screenings. Their core vision is to enhance the efficiency of healthcare providers by delivering real-time, quantified risk scores and health insights based on patient interactions. Aiberry's AI technology analyzes words, audio, and visual features during brief conversations, aiming to address challenges such as unquantifiable assessments, varying interpretations, and unconscious biases in traditional mental health evaluations.
Notable for its clinically validated assessments, Aiberry has garnered attention for its innovative approach to mental health diagnostics. The company’s platform has demonstrated significant impact in improving the reliability and efficiency of mental health screenings. By providing actionable insights and reducing the time required for assessments, Aiberry is making substantial strides in addressing the global mental health crisis. Their work is supported by a team of experts in AI and mental health, alongside investors committed to advancing healthcare technology.